Nathen E. Bopp

2.6k total citations
18 papers, 806 citations indexed

About

Nathen E. Bopp is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, Nathen E. Bopp has authored 18 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 8 papers in Public Health, Environmental and Occupational Health and 4 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in Nathen E. Bopp's work include Viral Infections and Vectors (8 papers), Mosquito-borne diseases and control (8 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Nathen E. Bopp is often cited by papers focused on Viral Infections and Vectors (8 papers), Mosquito-borne diseases and control (8 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Nathen E. Bopp collaborates with scholars based in United States, Paraguay and Colombia. Nathen E. Bopp's co-authors include Scott C. Weaver, Patricia V. Aguilar, Kenneth S. Plante, Xuping Xie, Vineet D. Menachery, Pei‐Yong Shi, Xianwen Zhang, Jing Zou, Craig Schindewolf and Kumari G. Lokugamage and has published in prestigious journals such as Cell, Nature Communications and Cell Host & Microbe.

In The Last Decade

Nathen E. Bopp

17 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathen E. Bopp United States 11 624 180 127 121 87 18 806
Chaitanya Kurhade United States 16 776 1.2× 235 1.3× 149 1.2× 140 1.2× 58 0.7× 22 929
Rachel S. Nargi United States 10 840 1.3× 316 1.8× 132 1.0× 66 0.5× 131 1.5× 15 997
Donghoon Chung United States 17 432 0.7× 218 1.2× 43 0.3× 254 2.1× 183 2.1× 40 834
Nicole R. Sexton United States 12 477 0.8× 116 0.6× 183 1.4× 62 0.5× 61 0.7× 18 639
Zengguo Cao China 10 737 1.2× 207 1.1× 146 1.1× 78 0.6× 131 1.5× 26 960
Adam Sateriale United States 17 511 0.8× 179 1.0× 120 0.9× 49 0.4× 193 2.2× 31 1.1k
Chan-Ki Min South Korea 10 389 0.6× 116 0.6× 52 0.4× 85 0.7× 89 1.0× 16 666
Jamie Lovaglio United States 15 427 0.7× 121 0.7× 39 0.3× 78 0.6× 172 2.0× 42 754
Sweety Samal India 15 282 0.5× 180 1.0× 143 1.1× 60 0.5× 316 3.6× 45 763

Countries citing papers authored by Nathen E. Bopp

Since Specialization
Citations

This map shows the geographic impact of Nathen E. Bopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathen E. Bopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathen E. Bopp more than expected).

Fields of papers citing papers by Nathen E. Bopp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathen E. Bopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathen E. Bopp. The network helps show where Nathen E. Bopp may publish in the future.

Co-authorship network of co-authors of Nathen E. Bopp

This figure shows the co-authorship network connecting the top 25 collaborators of Nathen E. Bopp. A scholar is included among the top collaborators of Nathen E. Bopp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathen E. Bopp. Nathen E. Bopp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Boor, Peter, Heather L. Stevenson, Bin Gong, et al.. (2023). Necrotizing plasma cell-rich aortitis and sudden cardiac death: Late sequelae of COVID-19?. Cardiovascular Pathology. 66. 107558–107558.
2.
Moncayo, Abelardo C., T. E. Moore, Nathen E. Bopp, et al.. (2023). West Nile Virus and Epizootic Hemorrhagic Disease Virus Co-Infection in a Novel Host at the Nashville Zoo. American Journal of Tropical Medicine and Hygiene. 108(4). 705–711. 3 indexed citations
3.
Liu, Yang, Xianwen Zhang, Jianying Liu, et al.. (2022). A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions. Nature Communications. 13(1). 4337–4337. 62 indexed citations
4.
Johnson, Bryan A., Yiyang Zhou, Kumari G. Lokugamage, et al.. (2022). Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis. PLoS Pathogens. 18(6). e1010627–e1010627. 86 indexed citations
5.
Fernández, Diana, Nathen E. Bopp, Efraín Benavides Ortiz, et al.. (2022). Arbovirus Antibody Seroprevalence in the Human Population from Cauca, Colombia. American Journal of Tropical Medicine and Hygiene. 107(6). 1218–1225. 8 indexed citations
6.
Zhang, Xianwen, Yang Liu, Jianying Liu, et al.. (2021). A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence. Cell. 184(8). 2229–2238.e13. 52 indexed citations
7.
Mendell, Nicole L., et al.. (2021). Mechanisms of Sporicidal Activity Induced by Ionized Hydrogen Peroxide in the Spores of Bacillus atrophaeus. Applied Biosafety. 26(3). 130–138. 1 indexed citations
8.
Freeman, James A., Victoria Shalhoub, Bryan A. Johnson, et al.. (2021). Analytical characterization of the SARS-CoV-2 EURM-017 reference material. Clinical Biochemistry. 101. 19–25. 4 indexed citations
9.
Plante, Kenneth S., Varun Dwivedi, Jessica A. Plante, et al.. (2021). Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2. Biomedicine & Pharmacotherapy. 138. 111457–111457. 28 indexed citations
10.
Diamond, Gill, Natalia Molchanova, Jennifer S Lin, et al.. (2021). Potent Antiviral Activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids. Pharmaceuticals. 14(4). 304–304. 44 indexed citations
11.
Bopp, Nathen E., Crystyan Siles, Carolina Guevara, et al.. (2021). Serological Responses in Patients Infected with Mayaro Virus and Evaluation of Cross-Protective Responses against Chikungunya Virus. American Journal of Tropical Medicine and Hygiene. 106(2). 607–609. 3 indexed citations
12.
Bopp, Nathen E., et al.. (2020). Baseline mapping of severe fever with thrombocytopenia syndrome virology, epidemiology and vaccine research and development. npj Vaccines. 5(1). 111–111. 40 indexed citations
13.
Shelite, Thomas R., Nathen E. Bopp, Abelardo C. Moncayo, et al.. (2020). Isothermal Recombinase Polymerase Amplification-Lateral Flow Point-of-Care Diagnostic Test for Heartland Virus. Vector-Borne and Zoonotic Diseases. 21(2). 110–115. 7 indexed citations
14.
Bopp, Nathen E., et al.. (2020). Multicycle Autoclave Decontamination of N95 Filtering Facepiece Respirators. Applied Biosafety. 25(3). 150–156. 26 indexed citations
15.
Xie, Xuping, Antonio E. Muruato, Kumari G. Lokugamage, et al.. (2020). An Infectious cDNA Clone of SARS-CoV-2. Cell Host & Microbe. 27(5). 841–848.e3. 348 indexed citations
16.
Choi, Hyeree, Sagar B. Kudchodkar, Emma L. Reuschel, et al.. (2019). Protective immunity by an engineered DNA vaccine for Mayaro virus. PLoS neglected tropical diseases. 13(2). e0007042–e0007042. 41 indexed citations
17.
Rojas, Alejandra, Nathen E. Bopp, Laura Mendoza, et al.. (2019). Real-time RT-PCR for the detection and quantitation of Oropouche virus. Diagnostic Microbiology and Infectious Disease. 96(1). 114894–114894. 20 indexed citations
18.
Chattopadhyay, Anasuya, Patricia V. Aguilar, Nathen E. Bopp, et al.. (2018). A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections. Vaccine. 36(27). 3894–3900. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026